Which pharma organisation has partnered with Merck KGaA and IAVI for development of SARS-CoV-2 neutralizing monoclonal antibodies?

Q. Which pharma organisation has partnered with Merck KGaA and IAVI for development of SARS-CoV-2 neutralizing monoclonal antibodies?

A. Bharat Biotechnology

B. Serum Institute

C. Cipla

D. Ranbaxy

Answer: Serum Institute